Navigation Links
ViroPharma Incorporated Honored by the National Organization for Rare Disorders
Date:5/18/2009

prove the lives of people with rare diseases. NORD represents the nearly 30 million Americans who have rare diseases.

About Cinryze(TM) (C1 esterase inhibitor (human))

Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor product that has been approved by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE. C1 inhibitor therapy has been used acutely for more than 35 years in Europe to treat patients with C1 inhibitor deficiency.

Cinryze has been generally well tolerated. The most common adverse reactions observed have been upper respiratory infection, sinusitis, rash and headache. No drug-related serious adverse events (SAEs) have been observed in clinical trials. Severe hypersensitivity reactions may occur. Thrombotic events have occurred in patients receiving high dose off-label C1 inhibitor therapy well above the approved treatment dosage regimen. With any blood or plasma derived product, there may be a risk of transmission of infectious agents, e.g. viruses and, theoretically, the CJD agent. The risk has been reduced by screening patients for prior exposure to certain virus infections and by manufacturing steps to reduce the risk of viral transmission including pasteurization and nanofiltration.

Cinryze is for intravenous use only. A dose of 1000 Units of Cinryze can be administered every 3 or 4 days for routine prophylaxis against angioedema attacks in HAE patients. Cinryze is administered at an injection rate of 1 mL per minute.

About Hereditary Angioedema

HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contac
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. ViroPharma To Acquire Lev Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Bill Jacobs Automotive, a group of car dealerships headquartered ... the Heartland Blood Center and offering free oil change coupons ... place Saturday, Jan. 18 at the Bill Jacobs Cadillac and ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46637 )  The Bill Jacobs ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... for cancer, today announced the appointment of Thomas C Reynolds ... over 20 years, development experience gained in the biotechnology industry, ... "I am delighted to welcome Tom at this transformative ...
(Date:1/15/2014)... January 15, 2014 Two champions of ... their sponsorship of an annual competition for middle and ... access to, innovative STEM study. The competition presents students ... Tests of Engineering Aptitude, Mathematics, and Sciences is ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 AudioNotch ... experimental new therapy for the treatment of tinnitus. Patients ... tinnitus frequency, and over a period of weeks to months, ... Sound Therapy in two forms: Notched Music and Notched White ...
Breaking Biology Technology:Join the Bill Jacobs Auto blood drive and receive a free oil change 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... Attention To ,The Sneak Thief of Sight, NEW ... one of the,main causes of blindness around the globe, ... have announced the first annual,World Glaucoma Day, to be ... marked,by awareness and educational events organized by glaucoma institutions ...
... Inc.,(Nasdaq: HOLX ) today announced that Patrick Sullivan, ... presenting at the Merrill,Lynch Global Pharmaceutical, Biotechnology and Medical ... Hyatt Hotel in New York, NY., Interested parties ... of,Hologic,s investor presentation on Tuesday, February 5, 2008 at ...
... AlphaVax has,assembled its Cytomegalovirus (CMV) Advisory Board to provide ... candidates through clinical,development. To be chaired by Dr. Robert ... -- Mark Schleiss, MD, Professor, Associate Head ... Legion Chair in the Department of Pediatrics and Director, ...
Cached Biology Technology:World Glaucoma Day Set for March 6th 2Hologic to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2AlphaVax Announces New CMV Advisory Board 2
(Date:4/23/2014)... of asthma, allergies and other chronic inflammatory disorders among ... part to their reduced exposure to the microbes that ... paper. , The article, published in the journal ... in urban centers who have less access to green ... a condition caused by immune system dysfunction. , When ...
(Date:4/23/2014)... their mid-thirties and forties, face a devastating prognosis: ... decades. "Mutant" protein clusters, long blamed for the ... primary focus of therapies in development by pharmaceutical ... Gerardo Lederkremer and Dr. Julia Leitman of Tel ... in collaboration with Prof. Ulrich Hartl of the ...
(Date:4/23/2014)... People who have had a stroke, often suffer motor ... a study conducted in Taiwan, that will be published ... but is currently freely available on-line as an unedited ... when one group of stroke victims had their own ... brain and a similar group did not, those who ...
Breaking Biology News(10 mins):Rural microbes could boost city dwellers' health 2Rural microbes could boost city dwellers' health 3On the defensive 2On the defensive 3Autologous stem cell therapy improves motor function in chronic stroke victims 2
... Jobs, livelihoods and ecotourism industries can benefit from having ... coral reefs, marine researchers say. Despite their small ... often get more attention, herbivorous fish play a vital ... support the livelihoods of 500 million people worldwide, say ...
... 8th May 2012. A group of researchers from the ... INAD (Hospital del Mar Neuropsychiatry and Addictions Institute) has ... general overview at a chemical, pharmacological and behavioural level ... the Recreational Drugs European Network, as a new abused ...
... It is increasingly recognized that chronic psychotropic drug ... Indeed, clinical studies in humans present an intriguing picture: ... may contribute to cortical gray matter loss in patients, ... and mania, may preserve gray matter in patients. ...
Cached Biology News:Weed-eating fish 'help protect jobs, livelihoods' 2Weed-eating fish 'help protect jobs, livelihoods' 3Internet and new drugs: A challenge for public health 2Psychiatric medication effects on brain structure 2
... buffered anti-freeze environment for enzyme conjugated antibodies ... low viscosity solution at -20C , ... sampling is convenient , Contains preservatives ... Protect enzyme conjugates during storage without ...
Request Info...
... on a new flow-through technology, automates all of ... of tissues on microscope slide formats. ... expression, in situ hybridization (ISH) localizes transcripts in ... to validate and confirm results obtained by in ...
... The Microarray Gene Frame® has been ... These frames feature the same dual ... Gene Frame® range for easy removal ... uniformity and there are three sizes ...
Biology Products: